ORIENT BIO INC. · (주)오리엔트바이오
Last · KSE₩1559.00-36.00 (-2.26%)close · yahoo · 8h ago
Market cap₩46.2B29.6M sh
P/E · TTM—fwd — · eps —
Beta0.00vs S&P 500
Div yield0.00%annual · TTM
52w range
₩1490.00₩3264.00
Volume13.4Ksession
| Revenue | ₩29.8B |
|---|---|
| Operating income | ₩-4.1B |
| Net income | ₩-4.6B |
| Free cash flow | ₩547.9M |
| Operating margin | -13.9% |
| Net margin | -15.3% |
| Return on equity | -6.6% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2024-06-20
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -43.1%
Documents
FormReporting forFiledFlags